Mendus AB (publ) Cash Flow Conversion Efficiency

Latest as of March 2026: -0.037x

Mendus AB (publ) cash flow conversion efficiency. Based on the latest financial reports, Mendus AB (publ) (IMMU) has a cash flow conversion efficiency ratio of -0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-20.80 Million ≈ $-2.24 Million USD) by net assets (Skr565.14 Million ≈ $60.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Mendus AB (publ) (2010–2025)

Cash flow conversion efficiency of Mendus AB (publ) from 2010 to 2025. This chart illustrates how Mendus AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Mendus AB (publ) for real-time trading data and today's change.

Mendus AB (publ) Cash Flow Conversion Ratio Explained

Mendus AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Mendus AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mendus AB (publ) ranked by their cash flow conversion efficiency. Also see IMMU company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
KWANGJIN WINTEC CO. Ltd KQ:090150	0.079x
Hyunwoo Industrial Co. LTD KQ:092300	0.056x
Drax Group PLC LSE:DRX	0.003x
GSE Co. Ltd KQ:053050	0.013x
ContextVision AB OL:CONTX	0.047x
T&R Biofab Co. Ltd KQ:246710	0.002x
DPS Resources Bhd KLSE:7198	-0.015x
Kleannara KO:004540	0.132x

Annual Cash Flow Conversion Efficiency for Mendus AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Mendus AB (publ) from 2010 to 2025. Review Mendus AB (publ) (IMMU) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr585.07 Million ≈ $62.96 Million	Skr-81.53 Million ≈ $-8.77 Million	-0.139x	-12.85%
2024-12-31	Skr645.15 Million ≈ $69.43 Million	Skr-79.67 Million ≈ $-8.57 Million	-0.123x	+46.53%
2023-12-31	Skr704.73 Million ≈ $75.84 Million	Skr-162.76 Million ≈ $-17.52 Million	-0.231x	-8.67%
2022-12-31	Skr514.44 Million ≈ $55.36 Million	Skr-109.33 Million ≈ $-11.77 Million	-0.213x	-1.12%
2021-12-31	Skr656.74 Million ≈ $70.68 Million	Skr-138.03 Million ≈ $-14.85 Million	-0.210x	-145.38%
2020-12-31	Skr661.09 Million ≈ $71.14 Million	Skr-56.63 Million ≈ $-6.09 Million	-0.086x	+83.98%
2019-12-31	Skr272.78 Million ≈ $29.36 Million	Skr-145.81 Million ≈ $-15.69 Million	-0.535x	-107.36%
2018-12-31	Skr406.04 Million ≈ $43.70 Million	Skr-104.67 Million ≈ $-11.26 Million	-0.258x	-5.20%
2017-12-31	Skr189.56 Million ≈ $20.40 Million	Skr-46.45 Million ≈ $-5.00 Million	-0.245x	+25.64%
2016-12-31	Skr102.39 Million ≈ $11.02 Million	Skr-33.74 Million ≈ $-3.63 Million	-0.330x	-14.00%
2015-12-31	Skr139.18 Million ≈ $14.98 Million	Skr-40.23 Million ≈ $-4.33 Million	-0.289x	+53.42%
2014-12-31	Skr64.63 Million ≈ $6.95 Million	Skr-40.10 Million ≈ $-4.32 Million	-0.621x	-570.22%
2013-12-31	Skr100.24 Million ≈ $10.79 Million	Skr-9.28 Million ≈ $-998.77K	-0.093x	+68.12%
2012-12-31	Skr24.60 Million ≈ $2.65 Million	Skr-7.15 Million ≈ $-769.03K	-0.290x	+31.50%
2011-12-31	Skr7.63 Million ≈ $820.73K	Skr-3.23 Million ≈ $-347.98K	-0.424x	+0.26%
2010-12-31	Skr3.92 Million ≈ $421.83K	Skr-1.67 Million ≈ $-179.31K	-0.425x	--

About Mendus AB (publ)

ST:IMMU Sweden Biotechnology

Market Cap

$35.28 Million

Skr327.87 Million SEK

Market Cap Rank

#22977 Global

#433 in Sweden

Share Price

Skr5.35

Change (1 day)

-1.47%

52-Week Range

Skr3.96 - Skr7.36

All Time High

Skr737.49